Influence of age and nutritional status on glycated albumin values in hemodialysis patients

Internal Medicine

Volumn 48, Issue 17, 2009, Pages 1495-1499

  Okada, Tomonari ^a   Nakao, Toshiyuki ^a   Matsumoto, Hiroshi ^a   Yamanaka, Tamami ^a   Nagaoka, Yume ^a   Tamekuni, Tokiyo ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Diabetes; End stage renal disease; Glycated albumin; Glycemic control; Hemodialysis

Indexed keywords

ALBUMIN; CHOLINESTERASE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MALE; NUTRITIONAL STATUS; PROTEIN METABOLISM; PROTEIN SYNTHESIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 70349487382     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2301     Document Type: Article

References (26)

1. Oomichi T, Emoto M, Tabata T, et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 29: 1496-1500, 2006.
2. Kalantar-Zadeh K, Kopple JD, Regidor DL, et al. A1c and survival in maintenance hemodialysis patients. Diabetes Care 30: 1049-1055, 2007.
3. Hashimoto Y, Fukuhara S, Akiba T, et al. Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study. Diabetologia 50: 1170-1177, 2007.
4. Nakao T, Matsumoto H, Okada T, et al. Influence of erythropoetin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 37: 826-830, 1998.
5. Ansari A, Thomas S, Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis 41: 523-531, 2003.
6. Chujo K, Shima K, Tada H, Oohashi T, Minakuchi J, Kawashima S. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Invest 53: 223-228, 2006.
7. Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 18: 896-903, 2007.
8. Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis. Kidney Int 73: 1062-1068, 2008.
9. Fukuoka K, Nakao K, Morimoto H, et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology 13: 278-283, 2008.
10. Okada T, Nakao T, Matsumoto H, et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal failure. Intern Med 46: 807-814, 2007.
11. Kumeda Y, Inaba M, Shoji S, et al. Significant correlation of glycated albumin, but not glycated hemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Clin Endocrinol 69: 556-561, 2008.
12. Yamada S, Inaba M, Shidara K, et al. Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetes. Life Sci 83: 516-519, 2008.
13. 1c as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 81: 258-262, 2008.
14. Koga M, Murai J, Saito H, Matsumoto S, Kasayama S. Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diabetes Res Clin Pract, first published on 24 February 2009 as doi: 10. 1016/j. diabres. 2009. 01. 013.
15. Miyashita Y, Nishimura R, Morimoto A, Matsudaira T, Sano H, Tajima N. Glycated albumin is low in obese, type 2 diabetic patients. Diabetes Res Clin Pract 78: 51-55, 2007.
16. Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chimica Acta 378: 48-52, 2007.
17. K/DOQI™ Clinical guidelines for nutrition in chronic renal failure. Rationale and methods for the determination of the protein equivalent of nitrogen appearance (PNA). Am J Kidney Dis 35 suppl 2 : S71-S74, 2002.
18. Kaysen GA, Dubin JA, Müller HG, et al. Relationship among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 61: 2240-2249, 2002.
19. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26: 61-69, 2003.
20. Chernoff R. Protein and older adults. J Am Coll Nutr 23: 627S-630S, 2004.
21. Caso G, Feiner J, Mileva I, et al. Response of albumin synthesis to oral nutrients in young and elderly subjects. Am J Clin Nutr 85: 446-451, 2007.
22. 1c values in elderly subjects. J Japan Diab Soc 52: 181, 2009 (in Japanese, Abstract).
23. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42: 864-881, 2003.
24. Akgul A, Bilgic A, Sezer S, et al. Effect of protein-energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients. Hemodial Int 11: 198-203, 2007.
25. Cuppari L, de Carvalho AB, Avesani CM, et al. Increased resting energy expenditure in hemodialysis patients with severe hyper-parathyroidism. J Am Soc Nephrol 15: 2933-2939, 2004.
26. Iglesias P, Diez JJ. Thyroid function and kidney disease. Eur J Endcrinol, first published on 18 December 2008 as doi: 10, 1530/ EJE-08-0837.